文献速递妇科

肿瘤浸润淋巴细胞预测接受同步放化疗的宫颈癌患者的生存结局

Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy.
PubMed 文献 · Gynecol Oncol · 2020-08-20

这项回顾性研究对55例在本机构接受顺铂为基础同步放化疗的晚期宫颈癌患者活检标本进行免疫染色,分析CD3、CD4、CD8、CD20、CD206和FOXP3阳性肿瘤浸润淋巴细胞与临床病理特征及生存的关系,并用流式细胞术分析15份新鲜标本中FOXP3阳性T细胞亚型。结果显示CD8阳性TIL浸润与盆腔淋巴结转移相关,CD3、CD4、CD8、CD206和FOXP3阳性TIL丰富浸润是更好无进展生存和总生存的统计学显著指标。

要点

  • CD8阳性肿瘤浸润淋巴细胞浸润与盆腔淋巴结转移相关。
  • CD3、CD4、CD8、CD206和FOXP3阳性TIL丰富浸润是更好无进展生存和总生存的统计学显著指标。
  • 15份新鲜肿瘤标本中均检测到FOXP3阳性TIL的非Treg亚型(Fr-III)。

核心结论

  • 多种特定肿瘤内TIL的丰富程度可能是接受同步放化疗的晚期宫颈癌患者的预后指标。

研究设计与样本

  • 回顾性研究,纳入55例在本机构接受顺铂为基础同步放化疗的晚期宫颈癌女性,对其阴道镜活检肿瘤内病灶行自动免疫染色(抗CD3、抗CD4、抗CD8、抗CD20、抗CD206和抗FOXP3六种鼠单克隆抗体)。
  • 另用流式细胞术分析15份额外新鲜肿瘤标本中FOXP3阳性TIL的亚型。

主要发现

  • CD8阳性TIL浸润与盆腔淋巴结转移相关。
  • CD3、CD4、CD8、CD206和FOXP3阳性TIL丰富浸润是更好无进展生存和总生存的统计学显著指标。
  • 在检测FOXP3阳性TIL亚型的全部样本中均发现非Treg(Fr-III)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To (i) identify correlations between selected immunogenic factors and clinicopathological characteristics, (ii) determine whether intratumoral abundance of various specific tumor-infiltrating lymphocytes (TILs) is a prognostic indicator in women with Stage II and III cervical cancer who undergo treatment with cisplatin-based concurrent chemoradiotherapy (CCRT), and (iii) investigate subtypes of FOXP3+ T cells in 15 fresh samples of cervical cancer. METHODS: In this retrospective study, intratumoral lesions in colposcopic biopsies from 55 women with advanced cervical cancer who subsequently underwent CCRT at our institution were subjected to automatic immunological staining using the following six mouse monoclonal antibodies: anti-CD3, anti-CD4, anti-CD8, anti-CD20, anti-CD206, and anti-FOXP3. Associations between the findings on automatic scoring of the number of each type of TIL in each specimen and various clinicopathological characteristics were analyzed, as were associations between the abundance of various specific types of TIL and survival. Subtypes of FOXP3+ TILs in 15 additional fresh tumor samples were also investigated using flow cytometry. RESULTS: Infiltration with CD8+ TILs was associated with pelvic lymph node metastasis. Abundant infiltration by CD3+, CD4+, CD8+, CD206+, and FOXP3+ TILs were statistically significant indicators of better progression-free and overall survival. Regarding subtypes of FOXP3+ TILs, non-Tregs (Fr-III) were found in all samples tested for this. CONCLUSIONS: The abundance of various specific intratumoral TILs may be prognostic indicators in patients with advanced cervical cancer undergoing CCRT.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Ohno A, Iwata T, Katoh Y, et al. Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy. Gynecol Oncol. 2020. PMID: 32829964. doi:10.1016/j.ygyno.2020.07.106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。